Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA9 | hg38_v1_chr7_-_27165517_27165545 | 0.23 | 2.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_88128049 Show fit | 9.94 |
ENST00000393750.3
ENST00000295834.8 |
fatty acid binding protein 1 |
|
chr4_-_68670648 Show fit | 4.12 |
ENST00000338206.6
|
UDP glucuronosyltransferase family 2 member B15 |
|
chr13_+_53028806 Show fit | 3.71 |
ENST00000219022.3
|
olfactomedin 4 |
|
chr4_-_71784046 Show fit | 3.31 |
ENST00000513476.5
ENST00000273951.13 |
GC vitamin D binding protein |
|
chr2_-_223602284 Show fit | 3.31 |
ENST00000421386.1
ENST00000305409.3 ENST00000433889.1 |
secretogranin II |
|
chr8_+_79611036 Show fit | 3.21 |
ENST00000220876.12
ENST00000518111.5 |
stathmin 2 |
|
chr10_-_95069489 Show fit | 2.94 |
ENST00000371270.6
ENST00000535898.5 ENST00000623108.3 |
cytochrome P450 family 2 subfamily C member 8 |
|
chr10_+_84173793 Show fit | 2.68 |
ENST00000372126.4
|
chromosome 10 open reading frame 99 |
|
chr16_-_55833186 Show fit | 2.59 |
ENST00000361503.8
ENST00000422046.6 |
carboxylesterase 1 |
|
chrX_-_13817279 Show fit | 2.43 |
ENST00000475307.1
|
glycoprotein M6B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 6.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 5.3 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.2 | 4.1 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 3.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.2 | 3.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.2 | 3.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 3.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.8 | 3.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 2.9 | GO:0006825 | copper ion transport(GO:0006825) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 9.9 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 3.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 3.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 3.4 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
0.1 | 3.3 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 3.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 2.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.9 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 1.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 9.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 5.0 | GO:0003823 | antigen binding(GO:0003823) |
0.9 | 4.7 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 4.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 4.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 3.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.8 | 3.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.3 | 3.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 2.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.4 | 2.6 | GO:0019862 | IgA binding(GO:0019862) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 2.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 2.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 5.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 4.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 3.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 3.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 3.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 2.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 2.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 2.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 1.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |